DOP26: Real-life dosing patterns and concomitant drug use among ustekinumab-treated patients with Crohn’s DiseaseECCO'20 Vienna 2020
DOP27: Transanal minimally invasive surgery (TAMIS) – A noval approach for treatment of pouch failureECCO'20 Vienna 2020
DOP37: Neoplastic lesions outside diseased area in Inflammatory Bowel Disease patients: A National Cohort StudyECCO'20 Vienna 2020
DOP38: Prevalence of fatigue in a severe Inflammatory Bowel Disease cohort highly exposed to biologicsECCO'20 Vienna 2020
DOP41: Low grade dysplasia prognosis and predictive factors for advanced neoplasia progression in the 21st century – a large multi-centre retrospective cohort studyECCO'20 Vienna 2020
DOP42: Impact of discontinuing thiopurines at anti-TNF initiation in Inflammatory Bowel Disease: A nationwide Danish cohort studyECCO'20 Vienna 2020
DOP43: The risk of extra-intestinal cancer in Inflammatory Bowel Disease (IBD): A systematic review and meta-analysis of population-based cohort studiesECCO'20 Vienna 2020
DOP44: Cancer risk in a high-incidence Inflammatory Bowel Disease population – a Faroese IBD cohort studyECCO'20 Vienna 2020
DOP45: Increased prevalence but not incidence of myocardial infarction and stroke in patients with Inflammatory Bowel Diseases in Quebec in 1996-2015ECCO'20 Vienna 2020
DOP47: The changing pattern of Inflammatory Bowel Disease incidence in Northern France: A continuing increase in the young women (1988-2014)ECCO'20 Vienna 2020
DOP48: Gene expression landscape of epithelial monolayer in Inflammatory Bowel DiseaseECCO'20 Vienna 2020
DOP49: Quantitative proteomics analysis of macrophages from Crohn’s Disease patients and infected with adherent-invasive Escherichia coliECCO'20 Vienna 2020
DOP51: Investigation on the role of Par4-associated cell polarity and associated barrier defects in Inflammatory Bowel DiseasesECCO'20 Vienna 2020